Literature DB >> 16817090

Vesicoamniotic shunting using a double-basket catheter appears effective in treating fetal bladder outlet obstruction.

Hye-Sung Won1, Sun-Kwon Kim, Jae-Yoon Shim, Pil Ryang Lee, Ahm Kim.   

Abstract

BACKGROUND: To estimate the effect of vesicoamniotic shunting using a double-basket catheter on treating fetal bladder outlet obstruction.
METHODS: A retrospective study involving 8 prenatally diagnosed bladder outlet obstruction cases that underwent vesicoamniotic shunt placement using a double-basket catheter from 1998 to 2004. Patients were followed-up for prenatal and neonatal outcome analyses.
RESULTS: Vesicoamniotic shunting was performed in 8 fetuses aged between 13.7 and 25.4 weeks' gestation (mean+/-SD, 19.7+/-3.5 weeks). Final diagnoses included 5 posterior urethral valves, 1 cloacal anomaly, 1 urethral stenosis, and 1 unknown. There were no maternal complications associated with the procedures. One woman diagnosed as having a fetus with posterior urethral valves decided to terminate her pregnancy and one fetus died in uterus spontaneously. Six women delivered live babies, and one baby required postnatal ventilatory support. Postnatal follow-up ranged from 3 to 60 months. Of the 6 newborns, 4 survived with normal renal function, 1 had renal insufficiency, and 1 died of renal failure at 3 months of age.
CONCLUSIONS: Vesicoamniotic shunt placement using a double-basket catheter may be effective in improving perinatal and neonatal outcomes through long-term decompression of the fetal urinary tract in carefully selected cases.

Entities:  

Mesh:

Year:  2006        PMID: 16817090     DOI: 10.1080/00016340500449923

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  1 in total

1.  Long-term outcomes of kidney and bladder function in patients with a posterior urethral valve.

Authors:  Sung Jin Kim; Jaeyoon Jung; Chanwoo Lee; Sejun Park; Sang Hoon Song; Hye-Sung Won; Kun Suk Kim
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.